Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 5,751–5,775 of 7,816 matching trials · page 231 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
The Effect of Rapid Transcranial Magnetic Stimulation (rTMS) on Aggression in Forensic Patients
NCT02990442
rTMS
Runs in: Canada · 1 site
NA
other
UNKNOWN 10 St. Joseph's Healthcare Hamilton
OTHER
2019-04-22
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
NCT00400062
Runs in: United States · 3 sites
NA
other
COMPLETED 800 VA Office of Research and Development
OTHER_GOV
2019-04-19
SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)
NCT02258152
SYN120; Placebo
Runs in: United States · 20 sites
PHASE2
other
COMPLETED 82 Biotie Therapies Inc.
INDUSTRY
2019-04-19
Plasticity-based Adaptive Cognitive Remediation for Alzheimer Disease
NCT02331784
Computerized Plasticity-based Software; Commercially available Video Game
Runs in: United States · 1 site
NA
other
COMPLETED 68 Posit Science Corporation
INDUSTRY
2019-04-19
Communication Skills vs. Mindfulness for IPV
NCT03672942
Communication Skills Training; Mindfulness; Placebo
NA
other
UNKNOWN 50 University of Houston
OTHER
2019-04-18
Effect of Digital Cognitive Training on the Functionality of Older Adults With Mild Cognitive Impairment (MCI)
NCT03911765
digital cognitive training
Runs in: Brazil · 1 site
PHASE1
other
UNKNOWN 40 Universidade Federal do Rio de Janeiro
OTHER
2019-04-17
Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
NCT02931136
Huperzine A; Placebo
Runs in: China · 1 site
PHASE4
other
UNKNOWN 300 Shanghai Mental Health Center
OTHER
2019-04-16
Connecting Through Caregiving: Reappraising Intergeneration Relationships
NCT03030027
Connecting Through Caregiving; Basic Skills Building
Runs in: Hong Kong · 1 site
NA
other
UNKNOWN 80 The Hong Kong Polytechnic University
OTHER
2019-04-16
Advanced Dementia and End-of-life
NCT03548142
provision of relevant information
Runs in: Germany · 1 site
NA
other
COMPLETED 38 Technical University of Munich
OTHER
2019-04-16
Transcranial Magnetic Stimulation and Cognitive Stimulation in Mild Cognitive Impairment
NCT03906903
Repetitive Transcranial Magnetic Stimulation; Cognitive Stimulation
Runs in: Mexico · 1 site
NA
other
UNKNOWN 20 Universidad Autonoma de Queretaro
OTHER
2019-04-16
Multi-center Imaging Genetics Studies in China
NCT02681822
Runs in: China · 1 site
NA
other
UNKNOWN 10,000 Tianjin Medical University General Hospital
OTHER
2019-04-10
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
NCT00198107
Aripiprazole; Placebo; D-cycloserine
Runs in: United States · 1 site
PHASE3
other
COMPLETED 81 Indiana University
OTHER
2019-04-09
The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia
NCT03906123
NBP; Placebos
Runs in: China · 1 site
NA
other
UNKNOWN 64 Tianjin Medical University General Hospital
OTHER
2019-04-08
Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
NCT01056965
davunetide (AL-108, NAP); Placebo nasal spray
Runs in: United States · 1 site
PHASE1
other
COMPLETED 12 University of California, San Francisco
OTHER
2019-04-05
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
NCT02632786
NEOD001; Placebo
Runs in: Australia; Austria; France; Germany; Greece; Israel; Ital... · 40 sites
PHASE2
other
COMPLETED 129 Prothena Biosciences Ltd.
INDUSTRY
2019-04-05
Ketamine Versus Midazolam for Prehospital Agitation
NCT03554915
Ketamine-based protocol; Midazolam-based protocol
Runs in: United States · 1 site
NA
other
COMPLETED 314 Hennepin Healthcare Research Institute
OTHER
2019-04-05
Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects
NCT00612872
[123I]CLINDE
Runs in: United States · 1 site
PHASE1
other
TERMINATED 46 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition
NCT00657813
MNI-330 as a brain SPECT tracer of Beta-Amyloid
Runs in: United States · 1 site
PHASE1
other
TERMINATED 3 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00870519
I-123-MNI-168; 123-I MNI-168
Runs in: United States · 1 site
PHASE1
other
TERMINATED 2 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease
NCT00886951
I123MNI388/I123MNI390
Runs in: United States · 1 site
PHASE1
other
TERMINATED 2 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Evaluation of [123I] MNI-340 and SPECT as a Marker of Beta-Amyloid Protein Deposition
NCT00968097
123-I MNI-340
Runs in: United States · 1 site
PHASE1
other
TERMINATED 12 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01028209
[18F] PBR06
Runs in: United States · 1 site
PHASE1
other
TERMINATED 12 Institute for Neurodegenerative Disorders
OTHER
2019-04-03
Detecting Dementia Earlier
NCT03900936
Neuropsychological tests
Runs in: United Kingdom · 1 site
NA
other
UNKNOWN 20 South Tees Hospitals NHS Foundation Trust
OTHER
2019-04-03
Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
NCT01834716
Aerobic vs. Non-Aerobic exercise
Runs in: United States · 1 site
NA
other
COMPLETED 16 Mayo Clinic
OTHER
2019-03-29
A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly
NCT02172612
Arm 1 Education Session
Runs in: United States · 1 site
NA
other
COMPLETED 50 Daniela Moga
OTHER
2019-03-29

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →